Third generation cephalosporins: safety profiles after 10 years of clinical use
- PMID: 2189900
- DOI: 10.1002/j.1552-4604.1990.tb03476.x
Third generation cephalosporins: safety profiles after 10 years of clinical use
Abstract
Compared with aminoglycosides, chloramphenicol, sulfonamides, tetracyclines, and even penicillins, the cephalosporins represent a remarkably safe class of antibiotics. Among the cephalosporins, the extended spectrum, third generation agents developed generally produce few side effects and appear to be less allergenic than the penicillins. Nephrotoxicity has not been a problem at recommended doses. Some third generation agents can cause hypoprothrombinemia if not administered with vitamin K, and disulfiram-like reactions occur with some agents because of the presence of a thiomethyl tetruzole moiety affixed to the cephem nucleus. There is a greater incidence of diarrhea associated with the agents excreted through a primarily biliary route, and this may contribute to the selection of drug resistant bacteria. Some agents are less active against staphylococci and their use may result in an increased incidence of superinfection or overgrowth of enterococci. If attention is given to the potential for adverse effects, many of these problems can be avoided and the third generation cephalosporins can be used safely in hospitals, nursing homes, and home care settings.
Similar articles
-
Third-generation cephalosporins: a critical evaluation.Clin Pharm. 1984 Jul-Aug;3(4):351-73. Clin Pharm. 1984. PMID: 6432420 Review.
-
Antibiotic use in neonatal sepsis.Turk J Pediatr. 1998 Jan-Mar;40(1):17-33. Turk J Pediatr. 1998. PMID: 9722468 Review.
-
Side effects of cephalosporins.Drugs. 1987;34 Suppl 2:105-20. doi: 10.2165/00003495-198700342-00009. Drugs. 1987. PMID: 3319495 Review.
-
Ceftizoxime. A review of its antibacterial activity, pharmacokinetic properties and therapeutic use.Drugs. 1985 Apr;29(4):281-329. doi: 10.2165/00003495-198529040-00001. Drugs. 1985. PMID: 3888599 Review.
-
Cephalosporin antibiotics.Mayo Clin Proc. 1983 Feb;58(2):79-87. Mayo Clin Proc. 1983. PMID: 6401833
Cited by
-
A review of the adverse events profile of cefpirome.Drug Saf. 1993 Nov;9(5):340-5. doi: 10.2165/00002018-199309050-00003. Drug Saf. 1993. PMID: 8280402 Review.
-
Antimicrobial activity of ceftriaxone compared with cefotaxime in the presence of serum albumin.Can J Infect Dis. 1995 Jan;6(1):21-7. doi: 10.1155/1995/617610. Can J Infect Dis. 1995. PMID: 22514377 Free PMC article.
-
Cefotaxime desensitization.Clin Investig. 1993 Feb;71(2):165-7. doi: 10.1007/BF00180000. Clin Investig. 1993. PMID: 8461630
-
Drug utilisation review (DUR) of the third generation cephalosporins. Focus on ceftriaxone, ceftazidime and cefotaxime.Drugs. 1995 Sep;50(3):423-39. doi: 10.2165/00003495-199550030-00002. Drugs. 1995. PMID: 8521766 Review.
-
Pharmacological properties of cephalosporins.Infection. 1991;19 Suppl 5:S244-52. doi: 10.1007/BF01645535. Infection. 1991. PMID: 1783440 Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical